1.900
+0,00%
2026-10-19
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -42.8% | +149.1% | 2 / 3 | +70.0% | -21.15 pp | -2.47 pp | +0.3% | 0.12 | 58.15 | 37,0 | +70,0% | 0,7 | −27,2% | 58.15 | 12.66 | +359,3% |
| Pts | 0 | 12 | 8 | 12 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 1.900 (close price on 2026-10-19)EPS (TTM): 32,7
Financial charts
1.Revenue & growth
VND bn37,0Q2/26
1.Revenue & growth
VND bn37,0Q2/26
2.Profit & growth
VND bn0,49Q2/26
3.Profit mix (Penman)
VND bn3,99Q2/26
4.Margins & cost structure
%10.2%Q2/26
5.Returns & cash cycle
% · days0.2%Q2/26
6.Earnings quality & cash
VND bn92,7Q2/26
7.Asset structure
VND bn680Q2/26
8.Funding & debt health
VND bn · times680Q2/26
9.Revenue backlog
VND bn3,18Q2/26
10.Valuation
times · %58,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %9Q2/26
Adjusted EPS growth, latest quarter
-42.8%
Average adjusted EPS growth, 3 quarters
-14.5%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26